Discovery of a novel anti-tumor agent targeting NF-kB pathway

被引：0
|
作者：
Ochi, H. [1 ]
Yanagi, T. [1 ]
Nakajo, M. [1 ]
Takemiya, A. [1 ]
Mochizuki, M. [1 ]
Oshima, H. [1 ]
Watanabe, W. [1 ]
Mishina, T. [1 ]
Nakamura, H. [1 ]
机构：
[1] Mitsubishi Pharma Corp, Div Pharmaceut Res, Yokohama, Kanagawa, Japan
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70586-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [1] Anti-tumor effect of a novel NF-KB activation inhibitor in bladder cancer cells
    Horiguchi, Y
    Nakashima, J
    Namekawa, J
    Murai, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 140 - 140
  • [2] IFN delivers an anti-apoptotic signal through a novel NF-kB pathway
    Yang, C
    Murti, A
    Kim, J
    Donner, D
    Pfeffer, L
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 308 - 308
  • [3] A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ
    Brassesco, Maria Sol
    Roberto, Gabriela Molinari
    Delsin, Lara Elis
    Baldissera, Gabriel Carlos
    Medeiros, Mariana
    Umezawa, Kazuo
    Tone, Luiz Gonzaga
    CHILDS NERVOUS SYSTEM, 2023, 39 (06) : 1519 - 1528
  • [4] Benzyl isothiocyanate potentiates the in vivo anti-tumor effects of gemcitabine against pancreatic cancer by targeting NF-kB and STAT3
    Boreddy, Srinivas Reddy
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2011, 71
  • [5] A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ
    María Sol Brassesco
    Gabriela Molinari Roberto
    Lara Elis Delsin
    Gabriel Carlos Baldissera
    Mariana Medeiros
    Kazuo Umezawa
    Luiz Gonzaga Tone
    Child's Nervous System, 2023, 39 : 1519 - 1528
  • [6] A novel NF-kB inhibitor DHMEQ could suppress peritoneal dissemination of gastric cancer by anti-tumor/-adhesive effects in mice
    Mino, K.
    Nakanishi, K.
    Haga, S.
    Sato, M.
    Kina, M.
    Yokoo, H.
    Kamiyama, T.
    Umezawa, K.
    Ozaki, M.
    Todo, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 399 - 400
  • [7] Dual Inhibition of Canonical and Non-Canonical NF-KB Pathway Demonstrates Significant Anti-Tumor Activities in Multiple Myeloma (MM)
    Fabre, Claire
    Mimura, Naoya
    Bobb, Kathryn
    Gorgun, Gullu
    Cirstea, Diana D.
    Hu, Yiguo
    Minami, Jiro
    Ohguchi, Hiroto
    Zhang, Jie
    Meshulam, Jeffrey
    Mitsiades, Constantine S.
    Richardson, Paul G.
    Hideshima, Teru
    Anderson, Kenneth C.
    BLOOD, 2011, 118 (21) : 1252 - 1252
  • [8] Targeting NF-KB Activation in Novel Intracranial Models of CNS Lymphoma
    Geng, Huimin
    Gao, Huaxin
    Kadoch, Cigall
    Lu, Ming
    Chen, Lingjing
    Anjum, Rana
    Drew, Lisa
    Degorce, Sebastien
    Dillman, Keith
    Mayo, Michele
    Anderson, Shawn
    Collins, Colin
    Lowell, Clifford A.
    Rubenstein, James L.
    BLOOD, 2016, 128 (22)
  • [9] Hypercapnic Acidosis And The Nf-Kb Pathway - Effects On P65 Subunit Of Nf-Kb
    Masterson, C. H.
    O'Toole, D. P.
    Laffey, J. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [10] Intratumoral cGAMP injection accumulates M1 macrophage in tumor via NF-kB/TLR4 pathway to enhance anti-tumor immunity
    Ohkuri, Takayuki
    Kosaka, Akemi
    Ishibashi, Kei
    Kinjo, Sonoko
    Yurino, Hideaki
    Ohara, Kenzo
    Hirata, Yui
    Oikawa, Kensuke
    Aoki, Naoko
    Nagato, Toshihiro
    Ikeo, Kazuho
    Hashimoto, Shin-ichi
    Kobayashi, Hiroya
    CANCER SCIENCE, 2018, 109 : 108 - 108
12345